Accuracy and precision in HER2/neu testing in breast cancer: are we there yet?

Hum Pathol. 2004 Feb;35(2):143-6. doi: 10.1016/j.humpath.2004.01.002.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use
  • Biomarkers, Tumor / analysis*
  • Breast Neoplasms / chemistry*
  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / drug therapy
  • DNA, Neoplasm / analysis
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunohistochemistry*
  • In Situ Hybridization, Fluorescence*
  • Predictive Value of Tests
  • RNA, Neoplasm / analysis
  • Receptor, ErbB-2 / analysis*
  • Receptor, ErbB-2 / genetics
  • Sensitivity and Specificity
  • Trastuzumab
  • Treatment Outcome
  • Up-Regulation

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Biomarkers, Tumor
  • DNA, Neoplasm
  • RNA, Neoplasm
  • Receptor, ErbB-2
  • Trastuzumab